PRFX News and Press, PainReform Ltd. From 07/22/21

India Globalization Capital (IGC) +128% announces issuance of Patent for the treatment of Alzheimer’s disease using THCPainReform (PRFX) +51%.ImmunoPrecise Antibodies IPA +41% highlights new data from TATX-03 SARS-CoV-2 Delta studySequential Brands (SQBG) +28%.NeuroMetri...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! It’s time to start off another busy day of trading with a look at the biggest pre-market stock movers for Thursday. Source: Shutterstock But let’s slow down for a second and get our beari...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Trxade Health (NASDAQ: MEDS ) stock is experiencing massive movement today as investors react to news of a deal from the company. Source: Shutterstock Let’s take a dive into the most recent MEDS stock ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re seeing lots of activity from penny stock PainReform (NASDAQ: PRFX ) on Wednesday despite a lack of news from the company. Source: Shutterstock What we are seeing is heavy trading of PRFX Stock. Th...

Chembio Diagnostics (CEMI) +93% on receiving $28.3M purchase order from Bio-Manguinhos for DPP SARS-CoV-2. Antigen Tests in BrazilLexaria Bioscience (LEXX) +42% as DehydraTECH significantly enhances delivery of Colchicine in study VIRAL-A20-3.PainReform (PRFX) +27%.Xtant Medica...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! We’re halfway through the week now but there’s no time to slack of yet. Let’s get ready for another busy day of trading with the pre-market stock movers for Wednesday! Source:...

Gainers: NeuroMetrix NURO +233%.NeuroBo Pharmaceuticals NRBO +92%.Staffing 360 Solutions (STAF) +38%.LSB Industries (LXU) +36%.Femasys (FEMY) +27%.Ideal Power (IPWR) +26%.Endo International plc ENDP +25%.PainReform (PRFX) +21%.LifeVantage Corporation (LFVN) +16%.Immunome IMNM&#...

PainReform (PRFX): Q1 net loss of $2.04MCash and cash equivalents of $19.42MPress Release For further details see: PainReform reports Q1 results

HERZLIYA, Israel, May 13, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today provided a business update for the first quarter ended Mar...

PainReform Ltd. (NASDAQ:PRFX) traded at a new 52-week low today of $3.16. So far today approximately 500,000 shares have been exchanged, as compared to an average 30-day volume of 136,000 shares. PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the re...